Impact of initial active engagement in self-monitoring with a telemonitoring device on glycemic control among patients with type 2 diabetes

Min-Kyung Lee, Kwang-Hyeon Lee, Seung-Hyun Yoo, Cheol-Young Park, Min-Kyung Lee, Kwang-Hyeon Lee, Seung-Hyun Yoo, Cheol-Young Park

Abstract

This study aimed to investigate the effect of patient engagement in self-monitoring with a telemonitoring device on glycemic control among patients with type 2 diabetes. We conducted a subanalysis of the telemonitoring device study in Kaiser Permanente Northern California members. We divided the telemonitoring group into 53 frequent and 54 infrequent users based on self-monitoring of blood glucose (SMBG) frequency of the first 6 weeks. The frequency of SMBG transmitted from the telemonitoring device was examined over 24 weeks. Clinic and laboratory tests were collected at baseline, 6 weeks and 6 months. There was no significant difference in baseline HbA1c level between the two groups. After 6 months, change in HbA1c was -2.4 ± 1.6% among frequent users and -1.5 ± 1.5% among infrequent users (p = 0.003). The proportion of patients achieving target HbA1C level at 6 months was significantly higher among frequent users than among infrequent users. An increased frequency of SMBG was significantly correlated with a reduction in HbA1c at 6 months. In conclusion, initial active engagement in self-monitoring with a telemonitoring device could provide incremental improvement of glycemic control over 6 months.

Conflict of interest statement

K.H.L. was employed by 2Samsung Electronics Co. Ltd., Health R&D Group.

Figures

Figure 1
Figure 1
Proportion of patients achieving target HbA1C at 6 months.
Figure 2
Figure 2
Frequency of weekly self-monitoring of blood glucose (SMBG) in the telemonitoring group. Data are expressed as mean ± SEM.

References

    1. American Diabetes Association Standards of medical care for patients with diabetes mellitus. Diabetes Care. 2003;26:S33–S50. doi: 10.2337/diacare.26.7.2194.
    1. Williams R, Van Gaal L, Lucioni C. Assessing the impact of complications on the costs of Type II diabetes. Diabetologia. 2002;45:S13–S17. doi: 10.1007/s00125-002-0859-9.
    1. Haas L, et al. National standards for diabetes self-management education and support. Diabetes Care. 2014;37(Suppl 1):S144–S153. doi: 10.2337/dc14-S144.
    1. Norris SL, Engelgau MM, Narayan KM. Effectiveness of self-management training in type 2 diabetes: a systematic review of randomized controlled trials. Diabetes Care. 2001;24:561–587. doi: 10.2337/diacare.24.3.561.
    1. Brown SA. Interventions to promote diabetes self-management: state of the science. The Diabetes educator. 1999;25:52–61. doi: 10.1177/014572179902500623.
    1. Bellazzi R. Telemedicine and diabetes management: current challenges and future research directions. Journal of diabetes science and technology. 2008;2:98–104. doi: 10.1177/193229680800200114.
    1. Farmer A, Gibson OJ, Tarassenko L, Neil A. A systematic review of telemedicine interventions to support blood glucose self-monitoring in diabetes. Diabetic medicine: a journal of the British Diabetic Association. 2005;22:1372–1378. doi: 10.1111/j.1464-5491.2005.01627.x.
    1. Health Quality Ontario Home telemonitoring for type 2 diabetes: an evidence-based analysis. Ontario health technology assessment series. 2009;9:1–38.
    1. Pare G, Poba-Nzaou P, Sicotte C. Home telemonitoring for chronic disease management: an economic assessment. International journal of technology assessment in health care. 2013;29:155–161. doi: 10.1017/S0266462313000111.
    1. Yoo HJ, et al. A Ubiquitous Chronic Disease Care system using cellular phones and the internet. Diabetic medicine: a journal of the British Diabetic Association. 2009;26:628–635. doi: 10.1111/j.1464-5491.2009.02732.x.
    1. Mushcab H, Kernohan WG, Wallace J, Martin S. Web-Based Remote Monitoring Systems for Self-Managing Type 2 Diabetes: A Systematic Review. Diabetes technology & therapeutics. 2015;17:498–509. doi: 10.1089/dia.2014.0296.
    1. Wakefield BJ, et al. Effect of home telemonitoring on glycemic and blood pressure control in primary care clinic patients with diabetes. Telemedicine journal and e-health: the official journal of the American Telemedicine Association. 2014;20:199–205. doi: 10.1089/tmj.2013.0151.
    1. Graffigna G, Barello S, Bonanomi A, Menichetti J. The Motivating Function of Healthcare Professional in eHealth and mHealth Interventions for Type 2 Diabetes Patients and the Mediating Role of Patient Engagement. Journal of diabetes research. 2016;2016:2974521. doi: 10.1155/2016/2974521.
    1. Pressman AR, et al. A novel telemonitoring device for improving diabetes control: protocol and results from a randomized clinical trial. Telemedicine journal and e-health: the official journal of the American Telemedicine Association. 2014;20:109–114. doi: 10.1089/tmj.2013.0157.
    1. Armbruster DA. Fructosamine: structure, analysis, and clinical usefulness. Clinical chemistry. 1987;33:2153–2163.
    1. Currell R, Urquhart C, Wainwright P, Lewis R. Telemedicine versus face to face patient care: effects on professional practice and health care outcomes. The Cochrane database of systematic reviews. 2000;2:Cd002098.
    1. Stone RA, et al. Active care management supported by home telemonitoring in veterans with type 2 diabetes: the DiaTel randomized controlled trial. Diabetes Care. 2010;33:478–484. doi: 10.2337/dc09-1012.
    1. Sarol JN, Jr., Nicodemus NA, Jr., Tan KM, Grava MB. Self-monitoring of blood glucose as part of a multi-component therapy among non-insulin requiring type 2 diabetes patients: a meta-analysis (1966-2004) Current medical research and opinion. 2005;21:173–184. doi: 10.1185/030079904X20286.
    1. Davidson, M. B. Self-monitoring of blood glucose in patients with type 2 diabetes who are not using insulin: response to Welschen et al. and Kleefstra et al. Diabetes Care28, 2597; author reply 2597–2598 (2005).
    1. International Diabetes Federation. IDF Guideline on Self-Monitoring of Blood Glucose in Non-Insuling Treated Type 2 Diabetes (International Diabetes Federation: Brussels, 2009).
    1. Allemann S, Houriet C, Diem P, Stettler C. Self-monitoring of blood glucose in non-insulin treated patients with type 2 diabetes: a systematic review and meta-analysis. Current medical research and opinion. 2009;25:2903–2913. doi: 10.1185/03007990903364665.
    1. Miller KM, et al. Evidence of a strong association between frequency of self-monitoring of blood glucose and hemoglobin A1c levels in T1D exchange clinic registry participants. Diabetes Care. 2013;36:2009–2014. doi: 10.2337/dc12-1770.
    1. Harris MI. Frequency of blood glucose monitoring in relation to glycemic control in patients with type 2 diabetes. Diabetes Care. 2001;24:979–982. doi: 10.2337/diacare.24.6.979.
    1. Wasson J, et al. Telephone care as a substitute for routine clinic follow-up. Jama. 1992;267:1788–1793. doi: 10.1001/jama.1992.03480130104033.
    1. Kim HS, Cho JH, Yoon KH. New Directions in Chronic Disease Management. Endocrinology and metabolism (Seoul, Korea) 2015;30:159–166. doi: 10.3803/EnM.2015.30.2.159.
    1. Sherbourne CD, Hays RD, Ordway L, DiMatteo MR, Kravitz RL. Antecedents of adherence to medical recommendations: results from the Medical Outcomes Study. Journal of behavioral medicine. 1992;15:447–468. doi: 10.1007/BF00844941.
    1. Renard E. Monitoring glycemic control: the importance of self-monitoring of blood glucose. The American journal of medicine. 2005;118:S12–S19. doi: 10.1016/j.amjmed.2005.07.052.
    1. Karter AJ, et al. Longitudinal study of new and prevalent use of self-monitoring of blood glucose. Diabetes Care. 2006;29:1757–1763. doi: 10.2337/dc06-2073.
    1. Standards of Medical Care in Diabetes-2016 Abridged for Primary Care Providers. Clinical diabetes: a publication of the American Diabetes Association 34, 3–21 (2016).
    1. Kim JM, Lee HJ, Kim KO, Won JC, Ko KS. Clinical Evaluation of OneTouch Diabetes Management Software System in Patients with Type 2 Diabetes Mellitus. Diabetes Metab J. 2016;40:129–139. doi: 10.4093/dmj.2016.40.2.129.
    1. Bijl JV, Poelgeest-Eeltink AV, Shortridge-Baggett L. The psychometric properties of the diabetes management self-efficacy scale for patients with type 2 diabetes mellitus. Journal of advanced nursing. 1999;30:352–359. doi: 10.1046/j.1365-2648.1999.01077.x.
    1. Al-Khawaldeh OA, Al-Hassan MA, Froelicher ES. Self-efficacy, self-management, and glycemic control in adults with type 2 diabetes mellitus. Journal of diabetes and its complications. 2012;26:10–16. doi: 10.1016/j.jdiacomp.2011.11.002.
    1. Gao J, et al. Effects of self-care, self-efficacy, social support on glycemic control in adults with type 2 diabetes. BMC family practice. 2013;14:66. doi: 10.1186/1471-2296-14-66.
    1. Sarkar U, Fisher L, Schillinger D. Is self-efficacy associated with diabetes self-management across race/ethnicity and health literacy? Diabetes Care. 2006;29:823–829. doi: 10.2337/diacare.29.04.06.dc05-1615.

Source: PubMed

스폰서 및 공동 작업자

건강 상태

약물 개입

3
구독하다